Acute Transverse Myelitis in a Child with Down Syndrome After Pfizer-BioNTecH COVID-19 Vaccine Second Dose
PDF
Cite
Share
Request
Case Report
VOLUME: 1 ISSUE: 2
P: 47 - 49
August 2022

Acute Transverse Myelitis in a Child with Down Syndrome After Pfizer-BioNTecH COVID-19 Vaccine Second Dose

Curr Res MRI 2022;1(2):47-49
1. Department of Pediatric Neurology, University of Health Science, Adana City Training and Research Hospital, Adana, Turkey
No information available.
No information available
Accepted Date: 15.11.2022
Online Date: 15.11.2022
Publish Date: 15.11.2022
PDF
Cite
Share
Request

Abstract

Many pediatric and adult cases of acute transverse myelitis secondary to COVID-19 infection have been reported in the literature so far, but vaccine-related acute transverse myelitis is very rare. In fact, there have been no reported cases in children until now. Vaccination in children is vital both in the prevention of disease and continuing their social life and education. Hence, we believe that it is essential to follow up and report all of the complications that may occur after vaccination.

Cite this article as

Saricecili E, Çelik Ü, Dilek O, Özdemir U. Acute transverse myelitis in a child with down syndrome after pfizerBioNTecH COVID-19 vaccine second dose. Current Research in MRI. 2022; 1(2): 47-49.

Keywords:
COVID-19, Down syndrome, transverse myelitis, vaccine